Business Description

Mentor Capital Inc
NAICS : 523999
SIC : 6799
Description
Mentor Capital Inc acquires and provides liquidity for medical and social use cannabis companies. The company is operating an acquisition and investment business. It operates through two segments namely Cannabis and Medical Marijuana Segment and Facilities Operations related. The cannabis and medical marijuana segment include the operation of subsidiaries in the Cannabis and medical marijuana sector. Mentor's focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson's disease, reducing ocular pressures from glaucoma, and blunting chronic pain.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.24 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 1.54 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.61 | |||||
Beneish M-Score | -4.69 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.7 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | -2.3 | |||||
3-Year Book Growth Rate | -30.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.19 | |||||
9-Day RSI | 55.34 | |||||
14-Day RSI | 53.28 | |||||
6-1 Month Momentum % | 34.44 | |||||
12-1 Month Momentum % | -2.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.63 | |||||
Cash Ratio | 0.98 | |||||
Days Sales Outstanding | 33.41 | |||||
Days Payable | 2.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.67 | |||||
Operating Margin % | -14.37 | |||||
Net Margin % | 0.94 | |||||
ROE % | 3.17 | |||||
ROA % | 1.34 | |||||
ROIC % | -24.54 | |||||
ROC (Joel Greenblatt) % | 54.55 | |||||
ROCE % | 13.58 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.17 | |||||
PE Ratio without NRI | 17.17 | |||||
Price-to-Owner-Earnings | 1.2 | |||||
PS Ratio | 0.16 | |||||
PB Ratio | 0.54 | |||||
Price-to-Tangible-Book | 1.72 | |||||
Price-to-Free-Cash-Flow | 0.94 | |||||
Price-to-Operating-Cash-Flow | 0.92 | |||||
EV-to-EBIT | 1.59 | |||||
EV-to-EBITDA | 1.1 | |||||
EV-to-Revenue | 0.12 | |||||
EV-to-FCF | 0.71 | |||||
Price-to-Graham-Number | 1.03 | |||||
Earnings Yield (Greenblatt) % | 62.89 |